In this webinar, learn how the Duke Heart Center launched a fully digital, decentralized clinical study leveraging Deloitte’s ConvergeHEALTH MyPath for Clinical platform powered by AWS to study the impact of COVID-19 on athletes’ heart health. Discover how this study could give us insights into the impact of COVID on elite athletes, as well as the role that cloud based digital platforms can play to accelerate recruitment and improve retention and event ascertainment to augment the in-person visits that would have been required in the past. Register now.
During this webinar, you’ll learn how you can generate up to 17% more deals that are 2x larger on average by delivering instant access to real-time customer data and insights, streamlining the contract creation process, connecting sales-facing tools with pricing and contracting systems, and bringing your front- and back-office teams together. Register Now.
In this webinar we help Controllers, VPs of Finance and other finance team members grapple with these questions. We will cover what it costs to bring your first drug to market, how your peers raise that required capital, when to start building your processes and people to meet the requirements for accessing public markets, and more. Register Now.
Companies can encounter a number of pitfalls on the path to moving a drug from preclinical to clinical trials. Understanding these hurdles—and properly preparing for them—can prevent a drug development program from stalling or, worse, stopping altogether. During this webinar, biopharma R&D professionals will review strategies for moving successfully and efficiently from preclinical studies to first-in-human trials. They will call upon their own experiences to provide advice that will help others in the industry navigate this crucial transition. Register Now.
Reports have shown that up to 69% of physicians want digital patient education and are up to 5X more responsive to messaging if personalized. The future of pharma is personalized omni-channel engagement, and that future is now. Join us to learn more about how we’re combining personalization with non-personal promotion to deliver 160:1 ROI for leading pharmaceutical brands. Register Now.
When your manufacturing process depends on healthcare professionals working with the patients to get the front-end and back-end of the processes exactly right, those professionals need to understand your process unequivocally. That may mean having a team of trainers to make that happen. We’ll discuss the challenges posed by this new wave of therapies and how the pioneers in the field are tackling them. Register Now.
AI-driven automation that delivers predictive insights and drives next-best action recommendations is of critical value to life sciences. Join us to discuss AI principles and see data science in action for life sciences use cases. Register now.
In the healthcare industry, innovation is essential. With so many medical products developed and launched daily, pharmaceutical, healthcare services, biotechnology, medical device, diagnostic, and life science companies should clearly understand if products fit the needs of the market. To answer this, you must identify what your customers perceive as valuable. Register now.
The research forecasts the continuation, as well as discontinuation, of certain approaches such as EHR, eSource, ePro, and patient apps – and the impact of these approaches on clinical trial data, quality , and speed. It will also shed light on the industry’s level of confidence in the data generated from these new clinical trial approaches and other expectations as we step forward into the post-pandemic world. Register Now.
Whether you’re designing a hub services program to match the unique needs of your emerging specialty product or considering a more tailored approach to your current hub strategy, this webinar will take a look at the essential interconnectivity between data and digital services. In this webinar, we will share answers to these questions and explore how technology, data, and analytics can be leveraged to create your hub success story. Register Now.
As the healthcare industry becomes more saturated with big data, the search continues for data that can inform decisions that positively impact the experience and outcomes of patients with cancer. This webinar will illustrate how life science stakeholders can use this data to answer important questions about the experience of real world patients with cancer. Register now.
At the core of designing and executing a successful commercial launch strategy is having the right data and insights to effectively plan, execute, and adapt quickly to the market. Medidata Acorn AI Commercial Data Solutions has supported 40% of the first-time drug launches in the US so far in 2021. This webinar will address the six critical factors to consider for a successful commercial launch strategy. Register Now.
In this 90-minute series of panel discussions, hosted by GCI Health in partnership with Fierce Pharma, experts, academics, and innovators across healthcare will share how, as communicators, we can leverage mobile tools and emerging platforms to deliver credible health information to new audiences, bridge the gaps that exist between emerging digital innovation and hard-to-reach patient communities, and engage patients through emotional marketing and communications to drive further adoption of emerging technologies and care delivery. Register Now.
Pierre-Simon LaPlace, a famed French scientist, stated “nature laughs at the difficulties of integration.” We have assembled a panel of integration experts to share their tips for overcoming those difficulties. Our experts discuss these challenges, and the solutions proven to resolve them. Register Now.
In this webinar, attendees will learn about the CALIPER program and how it established a comprehensive database of pediatric RIs for over 180 clinical biomarkers, how the stratification of cytokine results based on age and/or sex specific RIs is expected to facilitate more accurate interpretation of cytokine expression patterns, and about Ella™, a multi-analyte immunoassay technology the CALIPER team is using to investigate pediatric cytokine profiles. Register Now.
In a recent survey, 89% of clinical adjudication users agreed clinical adjudication provides value to clinical trials. Why? Because using unbiased experts to evaluate a drug or device against predetermined criteria helps determine patient safety and clinical efficacy. Join two Bioclinica experts for a discussion of these and other survey results to understand how they could impact your studies. Register Now.
In this webinar with Mark Uhlik from OncXerna Therapeutics, discover how the Xerna TME Panel was developed and can be used to understand the dominant biology of the tumor microenvironment and align to particular therapeutic modalities. Register Now.
An efficient supply chain is critical to any first launch in Europe. This webinar will identify and address the critical aspects that companies must consider when creating a distribution and financial infrastructure in Europe. Our expert panel will share their experiences, as well as discuss the key benchmarks and pitfalls on the journey to building the optimal supply chain infrastructure. Register Now.
This webinar will be looking at the holistic digital patient journey emphasizing crucial points of intersection of patients, payers and providers. The discussion will focus on how digital solutions can be optimally effective by not just providing a narrow service, but by engaging and empowering patients throughout their entire healthcare journey. Register Now.
Learn the regulatory, commercial, and scientific factors that enable a drug to be successfully brought to market. Our expert with over 30 years of industry experience presents the preclinical and clinical process in detail and explains how strategic decisions impact the success of the drug approval and launch. Register now.
In this webinar, we discuss the latest in library synthesis technology, and its use to build innovative libraries that harness structural and developability features to cover a wide range of antibody drug targets. We show how these libraries enable the discovery of high-affinity drug-like antibodies, often without the need for affinity maturation. Register Now.
Supply chain issues significantly impact biomanufacturers. The right support can make a cGMP chemical supply chain operate seamlessly. Thermo Scientific Production Chemicals and Services can help streamline supply chain management so you can focus on producing quality therapies and vaccines faster. Download the white paper today.
Learn about the latest advances in leveraging bespoke ctDNA testing in clinical trials. Find out how Signatera has been applied in early stage and late stage disease. Dive into New published and presented data across multiple tumor types. Discover improvements to clinical trial design with Signatera including: identifying early relapsers, enriching for patients potentially most likely to respond to therapy, accelerating time to trial readout, predicting clinical outcomes as early as 6 weeks into treatment. Register Now.
AWS and Accenture share how they help transform pharma manufacturing, supply chain and quality control processes to deliver more personalized products faster and improve the patient experience. Register Now.
Development of HPAPIs presents unique challenges for product containment and requires special consideration in equipment selection, operating procedures, and safety processes. This webinar will discuss how to classify HPAPIs in early development and share recommendations for safe product handling, from clinical manufacturing to commercialization. The speakers will also share the key advantages of using micronization technology for the development and manufacturing of HPAPIs. Register Now.
Join us to learn how to develop a robust first-in-human (FIH) regulatory CMC package for recombinant biological molecules by integrating the following activities into your project plan: progressively developing knowledge of the molecule’s critical quality attributes to justify the manufacturing and control strategy, planning for continuing development, and identifying opportunities to enhance with scientific advice. Register Now.
Join this webinar to explore how running a customer-centric organization leads to organisational agility, process efficiency, and ultimately faster speed of innovation. Register now.
In this webinar, you will learn physician’s current and expected futures use of genomic sequencing, the impact of genome sequencing on individual healthcare, views on how genome sequencing will change the practice of medicine, perspectives on physicians’ concerns about genome sequencing for their patients, and how genome sequencing is changing cancer treatment plans. Register Now.
Favorable regulatory outcomes and a high demand for novel and on-demand cell and gene therapies has poised viral vector manufacturing for a significant jump. With new efficiencies on the horizon, what does this mean for the future of these therapies and their potential to treat a wider patient population? Register now.
We’ll explore the landscape of technologies and services that match patients to clinical trials, providing feedback from CRO executives who have experience with them. Topics include how innovative technology is being harnessed to extract information from electronic medical records in order to identify the most appropriate patients for clinical trials, best practices for using social media to match patients to clinical trials, and more. Register Now.
Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more.
For biotech companies, knowing how & when to scale up processes can accelerate time to market. Download our free infographic to learn more about opportunities for scale-up from discovery to production, how outsourcing can save time & money across the pipeline, and solutions that can help you scale.
The stakes are too high for patients to leave decision-making to machines, but AI can lend administrative support that empowers staff and medical experts alike to carry out their jobs more effectively. This whitepaper addresses where AI can make the biggest impact in clinical trials. Download now.
Transform your clinical trial supply chain management today and learn how to create a roadmap for supply chain modeling using advanced simulation tools in which all the possible scenarios that could affect the supply chain are accounted for in the strategy. Download whitepaper now.
Advanced analytics is the key to extracting enormous value from an existing asset: your LIMS data. Discover the difference between a lab that uses digital tools and a digital lab. Integrate analytics into your lab informatics with LabVantage. Download whitepaper now.
Every biopharma sponsor faces the challenge of initiating, running and closing trials on time, but oncology studies pose several unique hurdles. Read our new whitepaper to learn more about how sponsors can gain a competitive edge in oncology trials. Download now.
Are you implementing an eTMF for the first time and don’t know where to start? Check out Trial Interactive’s eTMF Implementation Quick Guide to see the primary considerations you should focus on to reduce risks, maintain compliance, and establish effective eTMF processes. Download now.
New research explores the impact of the COVID-19 pandemic on clinical trial management, including the acceleration of decentralized clinical trials. This report provides invaluable insight into the key challenges and opportunities surrounding these changes in this new environment. Download the report.
This white paper will explore areas for pharma marketers to consider as they adapt to a privacy-first environment, including alternative one-to-one patient engagement approaches, first-party data strategies, implementation of contextual targeting, and opportunities to shift marketing spend to reach high-quality patient audiences. Register Now.
Navigating each phase of your small molecule’s journey with the right CMC strategy is a critical component to enable success. Register Now.
Join this interactive panel to explore the depths of radiomic data in clinical trials. Learn real world applications and practical strategies for radiomic use in clinical trials, personalized drug development and therapy response. Register Now.
This talk will discuss processes for the metabolism of a drug, referred to as ADME, and the safety testing to provide requisite information to move a drug through IND and into clinical trials. Prior to marketing a new drug and actually prior to administering a candidate drug to humans in clinical trials, it is important to ensure that drug will not only be effective in the therapeutic manner prescribed, but also be safe and not bring any undo harm to patients. If you are involved in the development of potential new therapeutics, this discussion will help you gain necessary knowledge to inform your drug development decisions. Register Now.
To learn how you can chart an optimal path from gene to the clinic by tailoring your cell line development program to match your molecule type, timelines, yield requirements and risk priorities, register for our webinar now.
This webinar will bring together experts in preclinical trial design, R&D efficiency and regulatory affairs to offer advice on how companies can best engage the FDA early in the research process. Topics include strategies for determining the best timeline for approaching the FDA with a new drug candidate, a review of new technologies designed to speed up preclinical testing, and ensuring the proper balance between streamlining preclinical research and gathering enough data to satisfy regulators. Register Now.
A data lake is a great first step to transforming real world data into real world evidence that can be trusted to make critical decisions that drive forward the life changing therapies that you bring to patients today and tomorrow. During this webinar, hear from ex-CTO of Kaiser Permanente, ex- Data strategy leader of Merck, AWS Cloud Life Science leader and the LS product leader from Innovaccer on why we all need to think ‘beyond the data lake’. Save Your Spot.
Many drug developers naturally turn to contract manufacturers, but even with the best, they need to stay deeply involved, and aware of what is happening with their CDMO. A manufacturing plant that runs into FDA concerns, even for something unrelated to your efforts, can still delay years of work and the rewards of a drug approval. We’ll look at the diverse set of tactics companies can use to forestall manufacturing disappointments, from recruitment to partnerships to regulatory communication and more. Register Now.
“GMP-Like” plasmid services are rapidly expanding in cell & gene therapy. Understanding what value this creates is important as suppliers innovate to support researchers through the stages of clinical development. Please take a short survey to provide clarity to the value proposition it may provide.
Cell therapies represent a burgeoning area of clinical research and given the current number of new INDs the FDA expects 10-20 cell and gene therapies approved annually by 2025¹. This white paper explores common pitfalls in the clinical development of these complex therapies, lessons learned and best practices supporting accelerated approvals and reduced costs. Download Now.
Is it time to rethink your approach to commercialization? Learn how the right partner and mix of solutions can put you on the path to delivering disruption innovation. Register Now.
COVID-19 has changed the way healthcare is delivered and taught consumers the benefits of technology-enabled continuous connectivity with their physicians, care teams and pharmacies. This enhanced connectivity creates opportunities to make progress on some of the health system’s most difficult problems, such as the issue of medication nonadherence, which compromises health outcomes for patients across a wide range of conditions. Download now.
Bringing Cell, gene-modified cell and gene therapies successfully through the clinical trial process introduces a level of supply chain risk, complexity and specialized requirements which are not yet fully understood. This infographic focuses on taking a closer look at unique clinical supply challenges and unique needs associated with cell and gene therapies. Download to Learn More.
Pharma brand managers have moved from traditional marketing models for many reasons. However, the now favored Omnichannel approach has been difficult to implement because it requires the discipline of a cross-channel strategy that seamlessly integrates content to provide consistency across multiple “buyer” physician touchpoints. This webinar covers how RWD can accelerate executing on a true omnichannel outreach. Register now.
This White Paper provides an introduction to real-time qPCR and discusses the different approaches to real-time qPCR, outlines considerations to help you quickly compare previously optimized qPCR assays with a new qPCR Master Mix, offers guidance for optimizing your real-time qPCR assay, and provides a tool for comparing qPCR reagent formulations. Download Now.
G protein-coupled receptors (GPCRs) are one of the most promising drug targets due to their pathophysiological role in the human body. However, at the same time, GPCRs have proven to be one of the most challenging targets for antibody drug development. This webinar will describe the use of next-generation DNA synthesis tools to overcome the DNA bottleneck in antibody-based GPCR drug discovery, the discovery and creation of both antagonistic and agonistic GLP-1R antibodies by panning this GPCR-focused phage display library on a GLP-1R overexpressing Chinese hamster ovary cell line, and more. Register Now.
To produce a drug product with ideal biopharmaceutical properties, formulators must understand the molecule’s characteristics and create optimal formulations by utilizing technologies and processes that address the unique challenges presented by each API. But accelerating drug development timelines can force innovators to opt for quick-to-clinic dosage form approaches which may lead to suboptimal performance in patients. Download this Executive Summary to learn more.
In this paper, readers will learn what hybrid virtual engagement looks like, how to match virtual engagement tactics with different meeting and audience types, how to incorporate virtual elements into face-to-face interaction, beyond table stakes like cost reduction and increased participation, the meaningful benefits of engaging virtually, and the foundational elements of a virtual-first strategy for medical device organizations. Download Now.
Read Unlearn’s whitepaper to learn about how novel trial designs with Digital Twins enable more efficient clinical trials, with higher power and smaller required sample sizes. Download now.
For decades, scientists have used sandwich ELISA assays as a reliable tool for understanding disease mechanism, progression, and prognosis. Download this paper now to learn which ELISA features are most important to scientific researchers in 2021, the impact of in-house validation studies to research workflows, and specifications to consider when purchasing ELISA assays for your research. Download Now.
While the rapid development of COVID-19 vaccines helped to wind down the pandemic, it also brought to light the many challenges involved in ramping up the production of injectables that must be made in sterile, aseptic environments. Several companies struggled to compress what’s normally a year-long process of getting up to speed into a matter of months. Such pitfalls can be avoided, however, by improving planning processes and adopting new technologies to streamline manufacturing. Register Now.
This webinar features a Catalent expert presenting a roadmap for formulation and process development that can aid in seamless scale-up. Another expert from EuroAPI will provide an overview of typical tech transfer and scale-up processes, highlighting how thermodynamic modelling, engineering modifications, API conservation and cleaning techniques in large scale settings can help optimize overall processes in terms of yield and run times. Register now.
The Webinar will cover challenges of MDR for sterile medical device manufacturing companies, phases of Design Control for the development process of sterile disposable medical devices, advantages of a one-stop-shop during development and production in MDR environment, and contract Manufacturing partnership. By attending the webinar, you will get insight on MDR requirements and their impact on the development of medical devices, relevance of adequate documentation during MDR conform development of sterile medical devices, and advantages of Contract Manufacturing as strategic partnership to fulfill MDR requirements--especially for pharmaceuticals companies. Register Now.
Realizing the full potential of viral vector-based therapies requires a successful manufacturing platform for AAV vectors. In this whitepaper, compare differences between AAV platforms and the pros and cons of each to help evaluate which option is best suited for your gene therapy. Download now.
Monica Commerford, Ph.D., Head of Regulatory Affairs at Thermo Fisher Scientific, discusses the strategies available to meet critical regulatory requirements to accelerate early to late state CMC product development. Register Now.
This survey examines the life science industry’s progress in reducing system and process complexity to improve data transparency, study execution, and simplify how partners work together throughout the trial lifecycle. The goal of this research is to understand the drives, benefits, and barriers of a unified and connected clinical operating model. Take the survey.
How do today’s patients engage in social networks? Learn what’s working for innovative health marketers as consumers facing chronic health conditions re-think the relationships and resources that help them manage their disease. Register now.
During the COVID-19 pandemic, several pharma companies moved so fast to develop vaccines that the amount of time between the sequencing of the virus to the introduction of the first three vaccines was less than a year. This Fierce webinar will include input from vaccine R&D professionals, including experts in clinical trial design, regulatory affairs and manufacturing. They will draw upon their own experiences in vaccine development to offer tips for incorporating elements of the successful COVID-19 vaccine rollout into future vaccine programs. Register Now.